1. Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression
   Jittima Tomacha et al, 2021, Frontiers in Pharmacology CrossRef
2. Eicosapentaenoic Acid Inhibits KRAS Mutant Pancreatic Cancer Cell Growth by Suppressing Hepassocin Expression and STAT3 Phosphorylation
   Ching-Feng Chiu et al, 2021, Biomolecules CrossRef
3. Protective Mechanism of Gandou Decoction in a Copper-Laden Hepatolenticular Degeneration Model: In Vitro Pharmacology and Cell Metabolomics
   Fengxia Yin et al, 2022, Frontiers in Pharmacology CrossRef
4. EMT Factors and Metabolic Pathways in Cancer
   Ilias Georgakopoulos-Soares et al, 2020, Frontiers in Oncology CrossRef
5. Dual Switch in Lipid Metabolism in Cervical Epithelial Cells during Dysplasia Development Observed Using Raman Microscopy and Molecular Methods
   Katarzyna Sitarz et al, 2021, Cancers CrossRef
6. Targeting dysregulated lipid metabolism in the tumor microenvironment
   Do-Hee Kim et al, 2023, Archives of Pharmacal Research CrossRef
7. Unravelling the role of obesity and lipids during tumor progression
   Junzhe Zhao et al, 2023, Frontiers in Pharmacology CrossRef
8. Predicting Panel of Metabolism and Immune-Related Genes for the Prognosis of Human Ovarian Cancer
   Lingyun Zhang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
9. Identification of formononetin as the active compound of CR‐SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co‐expression networks
   Chun Li et al, 2024, Chemical Biology & Drug Design CrossRef